Cargando…

Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells

[Image: see text] Triple-negative breast cancer (TNBC) tends to behave more aggressively compared to other breast cancer subtypes due to the lack of receptors and its limited targeting therapy. In recent years, nanotechnology advancement has led to the development of various nanoparticle platforms f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yurt, Fatma, Özel, Derya, Tunçel, Ayça, Gokbayrak, Ozde, Aktas, Safiye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372957/ https://www.ncbi.nlm.nih.gov/pubmed/37521641 http://dx.doi.org/10.1021/acsomega.3c02682

Ejemplares similares

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
por: Manoğlu, Berke, et al.
Publicado: (2023)

Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity
por: Aktaş, Tekincan Çağrı, et al.
Publicado: (2023)

Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
por: Qu, Na, et al.
Publicado: (2019)

Synthesis of new water-soluble ionic liquids and their antibacterial profile against gram-positive and gram-negative bacteria
por: Duman, Ali Niyazi, et al.
Publicado: (2019)

Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
por: Wan, Xu, et al.
Publicado: (2016)

High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer
por: Lin, Hsin-Che, et al.
Publicado: (2019)

Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin Nanoparticles
por: Niknejad, Hassan, et al.
Publicado: (2015)

Interactions of Self-Assembled Bletilla Striata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles
por: Zhang, Guangyuan, et al.
Publicado: (2019)

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
por: Yu, Zhen, et al.
Publicado: (2020)

Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
por: Manoochehri, Saeed, et al.
Publicado: (2013)

Radiolabeled Human Serum Albumin Nanoparticles Co-Loaded with Methotrexate and Decorated with Trastuzumab for Breast Cancer Diagnosis
por: Ekinci, Meliha, et al.
Publicado: (2023)

Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow
por: Kayapinar, Osman, et al.
Publicado: (2019)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
por: Ghebeh, Hazem, et al.
Publicado: (2021)

Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer
por: Barve, Minal, et al.
Publicado: (2022)

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics
por: Ünal, Sedat, et al.
Publicado: (2022)

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2022)

ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line
por: Hwang, Eunjoo, et al.
Publicado: (2018)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
por: Oh, Keun Sang, et al.
Publicado: (2016)

Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles
por: Ge, Zhaohui, et al.
Publicado: (2018)

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer
por: Wan, Zhong, et al.
Publicado: (2020)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study
por: Passos, Ioannis D, et al.
Publicado: (2023)

Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
por: Lv, Zhi-Dong, et al.
Publicado: (2022)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)

Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
por: Jurczyk, Magdalena, et al.
Publicado: (2022)

The Loading of Epigallocatechin Gallate on Bovine Serum Albumin and Pullulan-Based Nanoparticles as Effective Antioxidant
por: Li, Zikun, et al.
Publicado: (2022)

KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells
por: Jiang, Meng, et al.
Publicado: (2017)

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen, Rujing, et al.
Publicado: (2021)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

Preparation and characterization of chitosan microsphere loading bovine serum albumin
por: Sun, Qingshen, et al.
Publicado: (2012)

Durvalumab activity in previously treated patients who stopped durvalumab without disease progression
por: Sheth, Siddharth, et al.
Publicado: (2020)

Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Alsrhani, Abdullah, et al.
Publicado: (2023)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Durvalumab: First Global Approval
por: Syed, Yahiya Y.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8b5t3eh8ra63sdovpkmvvrn0p